Rapid aneuploid diagnosis of high-risk fetuses by fluorescence in situ hybridization - 11/09/11
Abstract |
OBJECTIVE: Our purpose was to develop fluorescence in situ hybridization to repetitive chromosome-specific sequences to detect chromosome aneuploidy faster than hybridization to unique targets or karyotyping. STUDY DESIGN: Aneuploidy involving chromosomes 13, 18, 21, X, and Y comprises 70% of chromosome abnormalities in 10- to 12-week fetuses, 95% of the phenotypically significant newborn chromosome abnormalities. Our improved 8-hour protocol used repetitive probes to label and count the number of these centromeric chromosome domains. RESULTS: This protocol correctly determined chromosome 13, 18, and 21 status in 50 of 50 unselected direct amniocyte samples and found abnormal patterns in 27 of 27 archived trisomy 21 cases. Altogether karyotyping confirmed 744 of 745 chromosome-specific repetitive sequence test results. CONCLUSION: This protocol rapidly tests abnormal fetuses and newborn infants in whom diagnosis is made at the initiation of labor or before urgent surgery when a cytogenetic result cannot be completed. (AM J OBSTET GYNECOL 1996;174:886-90.)
Le texte complet de cet article est disponible en PDF.Keywords : Prenatal diagnosis, aneuploidy, in situ hybridization, cytogenetics
Plan
From the Department of Obstetrics, Gynecology, and Reproductive Sciencesa and the Department of Pediatrics,b University of California, San Francisco. |
|
Supported in part by National Institute of Child Health and Human Development contract CRMC-86-14 (M.S.G.) and a Muscular Dystrophy Association grant (R.V.L.). |
|
Reprints not available from the authors. |
|
0002-9378/96 $5.00 + 0 6/1/68668 |
Vol 174 - N° 3
P. 886-890 - mars 1996 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?